Toxic models of upper motor neuron disease

Journal of the Neurological Sciences

Volumn 139, Issue SUPPL., 1996, Pages 53-59

  Ludolph, Albert C ^a   Spencer, Peter S ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Excitotoxicity; Free radical; Konzo; Motor neuron disease; Neurocassavaism; Neurolathyrism

Indexed keywords

3 OXALYLAMINOALANINE; FREE RADICAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; HUMAN; LATHYRISM; MONKEY; MOTOR NEURON DISEASE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029832232     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(96)00122-0     Document Type: Conference Paper

References (58)

1. Albers, J.W. and Bromberg, M.B. (1994) X-linked bulbospinomuscular atrophy (Kennedy's disease) masquerading as lead neuropathy. Muscle Nerve 17: 419-423.
2. Banea, M., Poulter, N., and Rosling, H. (1992) Shortcuts in cassava processing and risk of dietary cyanide exposure in Zaire. Food Nutr. Bull. 14: 137-143.
3. Beal, M.F. (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31: 119-130.
4. Bridges, R.J., Stevens, D.R., Kahle, J.S., Nunn, P.B., Kadri, M., and Cotman, C.W. (1989) Structure-function studies on N-oxalyl-di-amino-dicarboxylic acids and excitatory amino acid receptors: evidence that L-ODAP is a selective non-NMDA agonist. J. Neurosci. 9: 2073-2079.
5. Bridges, R.J., Hatalski, C., Shim, S.N., and Nunn, P.B. (1991) Gliotoxic properties of the Lathyrus excitotoxin beta-N-oxalyl-L-alpha,beta-di-aminopropionic acid-(beta-L-ODAP). Brain Res. 561: 262-268.
6. Brusa, R., Zimmermann, F., Koh, D.-S., Feldmeyer, D., Gass, P., Seeburg, P.H., and Sprengel, R. (1995) Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science 270: 1677-1681.
7. Castro-Alamancos, M.A., and Borrell, J. (1995) Contribution of NMDA and nonNMDA glutamate receptors to synchronized excitation and cortical output in the primary motor cortex of the rat. Brain Res. Bull. 37: 539-543.
8. Chalmers, G.R., Roy, R.R., and Edgerton, V.R. (1992) Adaptability of the oxidative capacity of motoneurons. Brain Res. 570: 1-10.
9. Cliff, J., Lundquist, P., Martensson, J., Rösling, H., and Sörbo, B. (1991) Association of high cyanide and low sulfur intake in cassava-induced spastic paraparesis. Lancet ii: 1211-1213.
10. Couratier, P., Hugon, J., Sindou, P., Vallat. J.M., and Dumas, M. (1993) Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors. Lancet 341: 265-268.
11. Dal Canto, M.C. and Gurney, M.E. (1994) Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am. J. Pathol. 145: 1271-1279.
12. Davidoff, R.A. (1990) The pyramidal tract. Neurology. 40: 332-339.
13. Elliott, J.L. and Snider, W.D. (1995) Parvalbumin is a marker of ALS-resistant motor neurons. NeuroReport 6:449-452.
14. Filiminoff, I.N. (1926) Zur pathologisch-anatomischen Charakteristik des Lathyrismus. Z. Ges. Neurol. Psychiatr. 105: 76-92.
15. Gannon, R.L., and Terrian, D.M. (1989) L-BOAA selectively enhances L-glutamate release from guinea pig hippocampal mossy fiber synaptosomes. Neurosci. Lett. 107: 289-294.
16. Gurney, M.E., Pu, H., Chiu, A.Y., Dal Canto, M.C., Polchow, C.Y., Alexander, D.D., Caliendo, J., Hentati, A., Kwon, Y.W., Deng, H.-X., Chen, W., Zhai, P., Sufit, R.L., and Siddique, T. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264: 1772-1775.
17. Henneberry, R.C., Novell, A., Cox, J.A., Lysko, P.G. (1989) Neurotoxicity at the N-methyl-D-aspartate receptor in energy-compromised neurons: A hypothesis for cell death in aging and disease. Ann. NY Acad. Sci. 568: 225-233.
18. Howlett, W.P., Brubaker, G.R., Mlingi, N., and Rösling, H. (1990) Konzo, an epidemic upper motor neuron disease studied in Tansania. Brain 113: 223-235.
19. Hugon, J., Ludolph, A., Roy, D.N., Schaumburg, H.H., and Spencer, P.S. (1988) Studies on the etiology and pathogenesis of motor neuron diseases. II. Clinical and electrophysiological features of pyramidal dysfunction in macaques fed Lathyrus sativus and IDPN. Neurology 38: 435-442.
20. Hugon, J., Ludolph, A.C., Spencer, P.S., Gimenez-Roldan, S., and Dumas, J.L. (1993) Studies on the etiology and pathogenesis of motor neuron diseases. III. Magnetic cortical stimulation in patients with lathyrism. Acta Neurol. Scand. 88: 412-416.
21. Ludolph, A.C., Hugon, J., Dwivedi, M.P., Spencer, P.S., and Schaumburg, H.H. (1987) Studies on the aetiology and pathogenesis of motor neuron diseases. I. Lathyrism: Clinical findings in established cases. Brain 110: 149-165.
22. Ludolph, A.C., He, F, Spencer, P.S., Hammerstad, J., and Sabri M. (1991) 3-Nitropropionic acid - exogenous animal neurotoxin and possible human striatal toxin. Canad. J. Neurol. Sci. 18: 492-498.
23. Martin, J.B. (1995) CNS genetic disorders: loss of function, gain of function, or something else? Curr. Opin. Neurobiol. 5: 669-673.
24. Mertens, H.G. (1947) Zur Klinik des Lathyrismus. Nervenarzt 18: 493-499.
25. Miller, S., P.B. Nunn, and R,I. Bridges (1993) Induction of astrocyte glutamine synthetase activity by the Lathyrus toxin beta-N-oxalyl-L-alpha,beta-diaminopropionic acid (beta-L-ODAP). Glia 7: 329-336.
26. Nihei, K., McKee, A.C., and Kowall, N.W. (1993) Patterns of neuronal degeneration of the motor cortex in amyotrophic lateral sclerosis. Acta Neuropathol. 86: 55-64.
27. Nunn, P.B., Seelig, M., Zagoren, J.C., and Spencer, P.S. (1987) Stereospecific acute neuronotoxicity of 'uncommon' plant amino acids linked to human motor-system diseases. Brain Res. 410: 375-379.
28. Olney, J.W., Misra, C.H., and Rhee, V. (1976) Brain and retinal damage from lathyrus excitotoxin, ß-N-oxalyl-L-alpha,beta-diaminopropionic acid. Nature 264: 659-661.
29. O'Reilly, J.P., Jiang, C., and Haddad, G. (1995) Major differences in response to graded hypoxia between hypoglossal and neocortical neurons. Brain Res. 683: 179-186.
30. Pai, K.S. and V. Ravindranath (1993) L-BOAA induces selective inhibition of brain mitochondrial enzyme, NADH-dehydrogenase. Brain Res. 621: 215-221.
31. Philips, C.G. and Porter, R. (1977) Corticospinal neurons: their role in movement. London, Academic Press.
32. Reiner, A., Medina, L., Figueredo-Cardenas, G., and Anfinson, S. (1995) Brainstem motoneuron pools that are selectively resistant in amyotrophic lateral sclerosis are preferentially enriched in parvalbumin: evidence from monkey brainstem for a calcium-mediated mechanism in sporadic ALS. Exp. Neurol. 131: 239-250.
33. Riepe, M.W., Hori, N., Ludolph, A.C., and Carpenter, D.O. (1995) Failure of neuronal ion exchange, not potentiated excitation causes excitotoxicity after inhibition of oxidative phosphorylation. Neuroscience 64: 91-97.
34. Riepe, M., Spencer, P.S., Lambein, F., Ludolph, A.C., and Allen, C.A. (1995) Toxicological and pharmacological activity investigations of components of Lathyrus sativus. Natural Toxins 3: 58-64.
35. Riepe, M.W., Niemi, W.N., Megow, D., Ludolph, A.C., and Carpenter, D.O. (1996) Preconditioning of energy metabolism in hippocampus after selective inhibition of succinic dehydrogenase activity. Exp. Neurol., in press.
36. Ross, S.M., Roy, D.N., and Spencer, P.S. (1985) ß-N-oxalylamino-L-alanine: action on high-affinity transport of neurotransmitters in rat brain and spinal cord synaptosomes. J. Neurochem. 44: 886-892.
37. Ross, S.M., Seelig, M., and Spencer, P.S. (1987) Specific antagonism of excitotoxic action of 'uncommon' amino acids assayed in organic mouse cortical cultures. Brain Res. 425: 120-127.
38. Ross, S.M., Roy, D.N., and Spencer, P.S. (1989) Beta-N-oxalyl-amino-L-alanine: action on glutamate receptors. J. Neurochem. 53: 710-715.
39. Rothstein, J.D., Jin, L., Dykes-Hoberg, M., and Kuncl, R.W. (1993) Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. USA 90: 6591-6595.
40. Sabri, M.I., Lystrup, B., Roy, D.N., and Spencer, P.S. (1995) Action of ß-N-Oxalylamino-L-alanine on mouse brain NADH-dehydrogenase activity. J. Neurochem. 65: 1842-1848.
41. Shaw, C.M., Papayannopoulou, T., and Stamatoyannopoulos, G. (1974) Neuropathology of cyanate toxicity in rhesus monkeys. Pharmacology 12: 166-176.
42. 3H]kainate. Brain Res. 655: 186-194.
43. Spencer, P.S. and Schaumburg, H.H. (1983) Lathyrism: a neurotoxic disease. Neurobehav. Toxicol. Teratol. 5: 625-629.
44. Spencer, P.S., Roy, D.N., Ludolph, A., Hugon, J., Dwivedi, M.P., and Schaumburg, H.H. (1986): Lathyrism: Evidence for role of the neuroexcitatory amino acid BOAA. Lancet ii: 1066-1067.
45. Spencer, P.S., Roy, D.N., Ludolph, A.C., Hugon, J., Dwivedi, M.P., and Schaumburg, H.H. (1988): Primate Model of Lathyrism: A Human Pyramidal Disorder. In: Neurodegenerative Disorders: the Role Played by Endotoxins and Xenobiotics (G. Nappi et al., eds.) Raven Press, New York, pp. 233-238.
46. Spencer, P.S. (1994) Lathyrism. In Vinken, P.J., Bruyn, G.W. (eds.) Handbook of Clinical Neurology 65. Intoxications of the nervous system, part II. Elsevier, North Holland, pp. 1-20.
47. Streifler, M., Cohn, D.F., Hirano, A., and Schujman, E. (1977) The central nervous system in a case of neurolathyrism. Neurology 27: 1176-1178.
48. Tekle-Haimanot, R., Kidane, Y., Wuhib, E., Kalissa, A., Alemu, T., Zein, Z.A., and Spencer, P.S. (1990) Lathyrism in rural northwestern Ethiopia: a highly prevalent neurotoxic disorder. Int. J. Epidemiol. 19: 664-672.
49. Trolli, G. (1938) Paraplégie spastique épidémique, 'Konzo', des indigànes du Kwango. In: Résumé des observations réunies, au Kwango, au sujet de deux affections d'órigine indéterminée (G. Trolli, ed.). Brussels: Fonds Reine Elisabeth, 1-36.
50. Tylleskär, T., Banca, M., Bikangi, N., Fresco, L., Persson, L.A., and Rösling, H. (1991) Epidemiological evidence from Zaire for a dietary aetiology of konzo, an upper motor neuron disease. Bull. World Health Organ. 69: 581-589.
51. Tylleskär, T., Banea, M., Bikanga, N., Cooke, R.D., Poulter, N.H., and Rosling, H. (1992) Cassava cyanogens and konzo, an upper motor neuron disease found in Africa. Lancet 339: 208-211.
52. Tylleskär, T., Hewlett, W.P., Rwiza, H.T., Aquilonius, S.-M., Stalberg, E., Linden, B., Mandahl, A., Larsen, H.C., Brubaker, G.R., and Rösling, H. (1993) Konzo, a distinct disease entity with selective upper motor neuron damage. J. Neurol. Neurosurg. Psychiatry 56: 638-644.
53. Willis, C.L., Meldrum, B.S., Nunn, P.B., Anderton, B.H., and Leigh, P.N. (1994) Neuroprotective effect of free radical scavengers on ß-N-oxalylamino-L-alanine (BOAA)-induced neuronal damage in rat hippocampus. Neurosci. Lett. 182: 159-162.
54. Wilson, J. (1994) Cyanogenic Glykosides In Vinken, P.J., Bruyn, G.W. (eds.) Handbook of Clinical Neurology 65. Intoxications of the nervous system, part II. Elsevier, North Holland, pp. 25-34.
55. Wong, P.C., Pardo, C.A., Borchelt, D.R., Lee, M.K., Copeland, N.G., Jenkins, N.A., Sisodia, S.S., Cleveland, D.W., and Price, D.L. (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14: 1105-1116.
56. Wong, P.C. and Borchelt, D.R. (1995) Motor neuron disease caused by mutations in superoxide dismutase 1. Curr. Opin. Neurol. 8: 294-301.
57. Wong-Riley, M.T.T. and Kageyama, G.H. (1986) Localization of cytochrome oxidase in the mammalian spinal cord and dorsal root ganglia, with quantitative analysis of anterior horn cells in monkeys. J. Comp. Neurol. 245: 41-61.
58. Wong-Riley, M.T.T. (1989) Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci. 12: 94-101.